Korrektur
Mavacamten in Nonobstructive Hypertrophic Cardiomyopathy
New England Journal of Medicine · 18.06.2026 · 394 (23) · 2384-2384
DOI: 10.1056/nejmx260016 ↗Kurz gefasst
Korrektur in der Zeitschrift New England Journal of Medicine, erschienen am 18.06.2026.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
(2026). Mavacamten in Nonobstructive Hypertrophic Cardiomyopathy. New England Journal of Medicine, 394(23), 2384-2384. https://doi.org/10.1056/nejmx260016
Vancouver
Mavacamten in Nonobstructive Hypertrophic Cardiomyopathy. New England Journal of Medicine. 2026;394(23):2384-2384. doi:10.1056/nejmx260016
BibTeX
@article{euvimed2026,
title = {Mavacamten in Nonobstructive Hypertrophic Cardiomyopathy},
journal = {New England Journal of Medicine},
year = {2026},
volume = {394},
number = {23},
pages = {2384--2384},
doi = {10.1056/nejmx260016}
}
EUVIMED